HS 300490 covers a broad residual category of retail-packaged medicaments not elsewhere classified, making it one of the highest-value and highest-volume pharmaceutical trade codes globally. India and China dominate as low-cost generic manufacturers and API suppliers, while Germany, Switzerland, and the US lead in branded and specialty formulations. Trade flows are heavily regulated, requiring import licenses, GMP certifications, and country-of-origin scrutiny due to counterfeiting risks and stringent pharmacovigilance requirements in destination markets.
HS Code 300490 covers Pharmaceutical Medicaments (Retail Pack) under the Harmonized System. It is used for customs declarations, import duty assessment, trade statistics, export documentation, and sourcing analysis.
Products classified under HS 300490 are used across Healthcare, Retail Pharmacy, Hospital Supply, Consumer Health. Demand is driven by Aging population, Rising chronic disease prevalence, Healthcare access expansion, Generic drug substitution.
Major exporting countries include Germany, Switzerland, United States, Italy, Slovenia based on recent international trade reporting.
Demand is linked to Aging population, Rising chronic disease prevalence, Healthcare access expansion, Generic drug substitution. Input costs are influenced by Active Pharmaceutical Ingredients (APIs).
Active US trade measures:
Verify final rates with HTSUS, TARIC, CBIC India, and a licensed customs broker.
US importers of Pharmaceutical Medicaments (Retail Pack) must classify at the HTS10 level. Additional measures such as Section 232, Section 301, ADD/CVD, or Chapter 99 provisions may apply depending on the exact classification and origin.
EU importers classify Pharmaceutical Medicaments (Retail Pack) at TARIC10 level. Preferential treatment may apply where rules of origin are satisfied under EU trade agreements. Intra-EU trade is duty-free.
India assesses Pharmaceutical Medicaments (Retail Pack) at the HS8 level under the CBIC Customs Tariff. The applicable duty framework is: BCD 10% + SWS 1% + IGST 5% = 16.66% effective gross rate. IGST is generally recoverable for registered B2B importers via GST filing.
Based on recent international trade data, the leading exporting countries for Pharmaceutical Medicaments (Retail Pack) are:
These corridors show where trade activity is concentrated. Buyers use this signal to identify supplier depth, established logistics lanes, and alternative sourcing markets.
| HS Code | 300490 |
| Product | Pharmaceutical Medicaments (Retail Pack) |
| Chapter | 30 — Pharmaceutical Products |
| Major exporting countries | Germany, Switzerland, United States, Italy, Slovenia |
| Primary industries | Healthcare, Retail Pharmacy, Hospital Supply, Consumer Health |
| Trade year | 2024 |
| US duty framework | HTS10 classification dependent |
| EU duty framework | TARIC10 classification dependent |
| India BCD | 10% BCD |
Logitality sourcing intelligence for HS 300490 combines global trade corridors, tariff data, commodity cost signals, FX movement, and supplier-country analysis to compare origins by estimated landed cost.
Compare supplier countries for HS 300490 by full duty stack and landed cost.
Run sourcing intelligence →Read the detailed sourcing guide for HS 300490 Pharmaceutical Medicaments (Retail Pack), including supplier-country analysis, trade-flow context, and procurement considerations.
HS Code 300490: Pharmaceutical Medicaments (Retail Pack) – Sourcing & Trade Guide 2025 →
HS Code 300490 covers Pharmaceutical Medicaments (Retail Pack) and is used for customs declarations, trade statistics, import duty assessment, and sourcing analysis.
Duty varies by destination and classification. US: HTS10 classification dependent. EU: TARIC10 classification dependent. India: 10% BCD.
Major exporting countries include Germany, Switzerland, United States, Italy, Slovenia, based on recent trade reporting.